Abstract
Hereditary breast cancers have unique clinicopathological characteristics. Therefore, the objective of this study was to establish the relationship between self-reported family history of cancer and clinicopathological features in breast cancer patients from Washington, DC. Data on incident breast cancer cases from 2000 to 2010 were obtained from the Washington, DC Cancer Registry. Variables such as estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) receptor status, as well as stage and grade, were analyzed in those that self-reported with (n = 1,734) and without a family history of cancer (n = 1,712). The breast cancer molecular subtypes were compared when ER, PR, and HER2 statuses were available. Furthermore, tumor characteristics were compared by race/ethnicity. Regression and chi-square analyses were performed. A report of family history was associated with age (OR = 1.27 95 % CI: 1.09–1.48; p < 0.0001), high grade tumors (OR = 1.29 95 % CI: 1.05–1.58; p = 0.02), and having ER and PR negative breast cancer (OR = 1.26 95 % CI: 1.02–1.57; p = 0.029). When tumor characteristics were compared by race/ethnicity, those that self-reported as African American with a family history had a higher frequency of ER negative tumors (OR = 1.51 95 % CI: 1.09–2.08; p = 0.008), PR negative tumors (OR = 1.46 95 % CI: 1.09–1.94; p = 0.028), grade 3 tumors (OR = 1.42 95 % CI: 1.05–1.93; p < 0.0001), and ER/PR negative tumors (OR = 1.5 95 % CI: 1.088–2.064; p = 0.01). These results suggest that a positive family history of cancer in African Americans should increase suspicions of hereditary cancer. Therefore, behavioral risk reduction activities, such as collecting a family history, may reduce late stage diagnosis and cancer mortality.
Similar content being viewed by others
References
(2005) Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrgen.htm
Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL, Leviton L (2000) Knowledge, attitudes, and behaviors of Alabama’s primary care physicians regarding cancer genetics. Acad Med 75(8):850–852
Armstrong K, Micco E, Carney A, Stopfer J, Putt M (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293(14):1729–1736
Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26(26):4282–4288
Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109(9):1721–1728
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL (2008) Early onset of breast cancer in a group of British black women. Br J Cancer 98(2):277–281
Burke W et al (2002) Genetics in primary care: a USA faculty development initiative. Community Genet 5(no. 2):138–146
Butterworth A (2007) Family history as a risk factor for common, complex disease. Public Health Genet
Carey LA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502
Daelemans S, Vandevoorde J, Vansintejan J, Borgermans L, Devroey D (2013) The use of family history in primary health care: a qualitative study. Adv Prev Med 2013, 695763
Flynn BS, Wood ME, Ashikaga T, Stockdale A, Dana GS, Naud S (2010) Primary care physicians’ use of family history for cancer risk assessment. BMC Fam Pract 11:45
Fuller M, Myers M, Webb T, Tabangin M, Prows C (2010) Primary care providers’ responses to patient-generated family history. J Genet Couns 19(1):84–96
Gramling R, Clarke J, Simmons E (2009) Racial distribution of patient population and family physician endorsed importance of screening patients for inherited predisposition to cancer. J Health Care Poor Underserved 20(1):50–54
Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA (2007a) Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome. Ann Surg Oncol 14(10):2994–3003
Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA (2007b) Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res 143(1):109–118
Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK, Neuhausen SL (2001) Knowledge, attitudes, and interest in breast–ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med 33(6):543–551
Lynch BJ, Holden JA, Buys SS, Neuhausen SL, Gaffney DK (1998) Pathobiologic characteristics of hereditary breast cancer. Hum Pathol 29(10):1140–1144
Matthews AK, Cummings S, Thompson S (2000) Genetic testing of African Americans for susceptibility to inherited cancers. J Psycological Oncol 18:1–13
Morris GJ et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results database. Cancer 110(4):876–884
Musolino A et al (2005) Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study. Tumori 91(6):505–512
Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C (2003) Breast cancer genetics in African Americans. Cancer 97(1 Suppl):236–245
Price RA, Blanchard JC, Harris RJ, Ruder T, Gresenz CR (2012) Monitoring cancer outcomes across the continuum: data synthesis and analysis for the District of Columbia. Technical Report. RAND Corporation
Rich EC, Burke W, Heaton CJ, Haga S, Pinsky L, Short MP, Acheson L (2004) Reconsidering the family history in primary care. J Gen Intern Med 19(3):273–280
Shields AE, Burke W, Levy DE (2008) Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med 10(6):404–414
Suther SG, Goodson P (2004) Texas physicians’ perceptions of genomic medicine as an innovation. Clin Genet 65(5):368–377
Thompson HS et al (2002) Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 11(12):1579–1585
Washington H (2006) Medical Apartheid: the dark history of medical experimentation on Black Americans from colonial times to the present. Doubleday Books
Wideroff L, Vadaparampil ST, Breen N, Croyle RT, Freedman AN (2003) Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet 6(no. 3):147–156
Williams JL, Collingridge DS, Williams MS (2011) Primary care physicians’ experience with family history: an exploratory qualitative study. Genet Med 13(1):21–25
Wood ME, Stockdale A, Flynn BS (2008) Interviews with primary care physicians regarding taking and interpreting the cancer family history. Fam Pract 25(5):334–340
Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ (2002) Can family history be used as a tool for public health and preventive medicine? Genet Med 4(4):304–310
Compliance and ethics
Experiments comply with the current laws of the US.
Financial support
This project has been funded in whole or in part with Federal funds from the National Center for Research Resources (NCRR-UL1RR031975), National Institutes of Health, through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, “Re-Engineering the Clinical Research Enterprise”; from the RCMI Program at Howard University, Division of Research Infrastructure, National Center for Research Resources, NIH (NCRR-G12 RR003048) and the Howard University Cancer Center/Johns Hopkins Cancer Center Partnership, National Cancer Institute (NCI-U54 CA091431).
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ricks, L.J., Ewing, A., Thompson, N. et al. Family history of cancer associated with breast tumor clinicopathological features. J Community Genet 5, 233–240 (2014). https://doi.org/10.1007/s12687-013-0180-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-013-0180-y